BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 8088609)

  • 1. Nuclear morphometry as a predictor of response to neoadjuvant chemotherapy plus radiotherapy in locally advanced cervical cancer.
    Yacoub SF; Shaeffer J; el-Mahdi AM; Faris L; Zhu A
    Gynecol Oncol; 1994 Sep; 54(3):327-32. PubMed ID: 8088609
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Neoadjuvant chemotherapy before radiotherapy in treatment of patients with cervical carcinoma].
    Li QS; Zhang XQ; Li DP; Sheng XG; Du XL; Song QQ
    Zhonghua Fu Chan Ke Za Zhi; 2006 Feb; 41(2):83-7. PubMed ID: 16640853
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A randomized study of primary bleomycin, vincristine, mitomycin and cisplatin (BOMP) chemotherapy followed by radiotherapy versus radiotherapy alone in stage IIIB and IVA squamous cell carcinoma of the cervix.
    Tabata T; Takeshima N; Nishida H; Hirai Y; Hasumi K
    Anticancer Res; 2003; 23(3C):2885-90. PubMed ID: 12926129
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pretreatment serum hemoglobin level as a predictive factor of response to neoadjuvant chemotherapy in patients with locally advanced squamous cervical carcinoma: a preliminary report.
    Fuso L; Mazzola S; Marocco F; Ferrero A; Dompè D; Carus AP; Zola P
    Gynecol Oncol; 2005 Dec; 99(3 Suppl 1):S187-91. PubMed ID: 16185756
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A feasibility study of topotecan with standard-dose cisplatin and concurrent primary radiation therapy in locally advanced cervical cancer.
    Gatcliffe TA; Tewari KS; Shah A; Brewster WR; Burger RA; Kuo JV; Monk BJ
    Gynecol Oncol; 2009 Jan; 112(1):85-9. PubMed ID: 18977518
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High complete response rate of concomitant chemoradiotherapy for locally advanced squamous cell carcinoma of the uterine cervix.
    Lin JC; Ho ES; Jan JS; Yang CH; Liu FS
    Gynecol Oncol; 1996 Apr; 61(1):101-8. PubMed ID: 8626094
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Concurrent chemoradiotherapy followed by adjuvant chemotherapy in uterine cervical cancer patients with high-risk factors.
    Kim YB; Cho JH; Keum KC; Lee CG; Seong J; Suh CO; Kim GE
    Gynecol Oncol; 2007 Jan; 104(1):58-63. PubMed ID: 16919718
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pelvic irradiation with concurrent chemotherapy versus pelvic and para-aortic irradiation for high-risk cervical cancer: an update of radiation therapy oncology group trial (RTOG) 90-01.
    Eifel PJ; Winter K; Morris M; Levenback C; Grigsby PW; Cooper J; Rotman M; Gershenson D; Mutch DG
    J Clin Oncol; 2004 Mar; 22(5):872-80. PubMed ID: 14990643
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical efficacy of modified preoperative neoadjuvant chemotherapy in the treatment of locally advanced (stage IB2 to IIB) cervical cancer: randomized study.
    Chen H; Liang C; Zhang L; Huang S; Wu X
    Gynecol Oncol; 2008 Sep; 110(3):308-15. PubMed ID: 18606439
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neoadjuvant chemotherapy in stage IB2 squamous cell carcinoma of the cervix.
    Serur E; Mathews RP; Gates J; Levine P; Maiman M; Remy JC
    Gynecol Oncol; 1997 May; 65(2):348-56. PubMed ID: 9159350
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of p53 and apoptosis of tumor cells in locally advanced cervical carcinoma after cisplatin based neoadjuvant chemotherapy.
    Garzetti GG; Ciavattini A; Provinciali M; Di Stefano G; Lucarini G; Goteri G; Biagini G
    Anticancer Res; 1996; 16(5B):3229-34. PubMed ID: 8920796
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Results of concomitant chemoradiation for cervical cancer using high dose rate intracavitary brachytherapy: study of JROSG (Japan Radiation Oncology Study Group).
    Sakata K; Sakurai H; Suzuki Y; Katoh S; Ohno T; Toita T; Kataoka M; Tanaka E; Kaneyasu Y; Uno T; Harima Y; Nakano T;
    Acta Oncol; 2008; 47(3):434-41. PubMed ID: 18348003
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Squamous cell carcinoma antigen in patients with locally advanced cervical carcinoma undergoing preoperative radiochemotherapy: association with pathological response to treatment and clinical outcome.
    Ferrandina G; Macchia G; Legge F; Deodato F; Forni F; Digesù C; Carone V; Morganti AG; Scambia G
    Oncology; 2008; 74(1-2):42-9. PubMed ID: 18544959
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Evaluation of neoadjuvant chemotherapy for locally advanced cervical cancinoma].
    Cheng XD; Lü WG; Ye F; Chen HZ; Xie X
    Zhonghua Fu Chan Ke Za Zhi; 2006 Feb; 41(2):95-8. PubMed ID: 16640856
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Histopathological findings in postoperative specimens in cervical cancer patients with stages IB2-IVA after neoadjuvant chemotherapy and preoperative plus postoperative radiotherapy.
    Kornovski Y; Gorchev G
    J BUON; 2007; 12(1):57-63. PubMed ID: 17436403
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment results of adjuvant chemotherapy after radical hysterectomy for intermediate- and high-risk stage IB-IIA cervical cancer.
    Takeshima N; Umayahara K; Fujiwara K; Hirai Y; Takizawa K; Hasumi K
    Gynecol Oncol; 2006 Nov; 103(2):618-22. PubMed ID: 16777200
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Concomitant chemobrachyradiotherapy with ifosfamide and cisplatin followed by consolidation chemotherapy for women with locally advanced carcinoma of the uterine cervix--final results of a prospective phase II-study.
    Vrdoljak E; Omrcen T; Novaković ZS; Jelavić TB; Prskalo T; Hrepić D; Hamm W
    Gynecol Oncol; 2006 Nov; 103(2):494-9. PubMed ID: 16814371
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neoadjuvant intraarterial chemotherapy followed by radical hysterectomy and/or radiotherapy for locally advanced cervical cancer.
    Sugiyama T; Nishida T; Hasuo Y; Fujiyoshi K; Yakushiji M
    Gynecol Oncol; 1998 May; 69(2):130-6. PubMed ID: 9600820
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mature results of a phase II trial of concomitant cisplatin/pelvic radiotherapy for locally advanced squamous cell carcinoma of the cervix.
    Fields AL; Anderson PS; Goldberg GL; Wadler S; Beitler J; Sood B; Runowicz CD
    Gynecol Oncol; 1996 Jun; 61(3):416-22. PubMed ID: 8641625
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Concurrent radiotherapy with paclitaxel/carboplatin chemotherapy as a definitive treatment for squamous cell carcinoma of the uterine cervix.
    Lee MY; Wu HG; Kim K; Ha SW; Kim JS; Kim IA; Lee HP
    Gynecol Oncol; 2007 Jan; 104(1):95-9. PubMed ID: 16996117
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.